Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease

Caffeine Suppresses Amyloid-β Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice

(2017) Chuanhai Cao et al.   JOURNAL OF ALZHEIMERS DISEASE

Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice

(2017) Gary W. Arendash et al.   JOURNAL OF ALZHEIMERS DISEASE

Calcium Ions Promote Formation of Amyloid β-Peptide (1–40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease

(2011) Anna Itkin et al.   PLoS One

Intrathecal corticosteroids might slow Alzheimer’s disease progression

(2011) Joseph Alisky   Neuropsychiatric Disease and Treatment

2010 Alzheimer's disease facts and figures

(2010)   Alzheimers & Dementia

In Vivo Responses of the Human and Murine Pregnane X Receptor to Dexamethasone in Mice

(2010) N. Scheer et al.   DRUG METABOLISM AND DISPOSITION

Protective actions of sex steroid hormones in Alzheimer’s disease

(2009) Christian J. Pike et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Preparation of fluorescently-labeled amyloid-beta peptide assemblies: the effect of fluorophore conjugation on structure and function

(2009) L. M. Jungbauer et al.   JOURNAL OF MOLECULAR RECOGNITION

Pregnane X Receptor (PXR) Regulates P-Glycoprotein at the Blood-Brain Barrier: Functional Similarities between Pig and Human PXR

(2009) M. Ott et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells

(2008) I S Haslam et al.   BRITISH JOURNAL OF PHARMACOLOGY

The pregnane X receptor: from bench to bedside

(2008) Xiaochao Ma et al.   Expert Opinion on Drug Metabolism & Toxicology

Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy

(2008) D. S. Miller et al.   PHARMACOLOGICAL REVIEWS